Mitral Valve Insufficiency Clinical Trial
Official title:
Magnetic Resonance Neurological Evaluation After Right Mini-thoracotomy Mitral Valve Surgery: Trans-thoracic Versus Endoaortic Clamp
The purpose of this study is to prospectively evaluate major and minor neurologic events in
patients undergoing right mini-thoracotomy mitral valve surgery and to compare different
aortic clamping techniques; specifically, the endoaortic balloon with retrograde perfusion
(Endoreturn) and the transthoracic clamp with retrograde perfusion. Major neurologic events
will be evaluate through standard neurologic evaluation; minor neurologic events will be
evaluate through magnetic resonance (MR) assessment.
The first aim of the study is to determine the number and impact of microembolic events
during right mini-thoracotomy mitral valve surgery on clinical neurological status and on MR
evaluation. The investigators also aim to determine if different techniques of aortic
clamping may impact on early outcome.
Study hypothesis: despite recent concerns arising about endoaortic balloon with retrograde
perfusion, the investigators expect to show equivalence in term of safety and effectiveness
of this technique compared with the transthoracic clamp in a selected population.
The incidence of neurologic events in right mini-thoracotomy mitral valve surgery compared
with that of conventional surgery is a controversial issue and has been extensively studied.
In the meta-analysis published by Modi et al, equal occurrence of neurologic events between
patients who underwent MIMVS and those who underwent a median sternotomy was found.
Conversely, the Thoracic Surgeons Adult Cardiac database and the Cleveland Clinic group
concluded that the risk of stroke is significantly higher in the less invasive group.
Moreover, recent data have suggested that retrograde arterial perfusion, particularly in
patients with severe arch/ascending aortic atherosclerosis, could be the source of the
significant increase in the incidence of cerebral complications. The meta-analysis of Cheng,
documents a 1.79 fold increase in the risk of stroke in the right thoracotomy group, but on
subgroup analysis this appeared driven by a higher stroke risk in those studies reporting
endoaortic balloon occlusion and not transthoracic clamping. Murzi et al. report a 4.28 fold
increase in stroke risk with RAP in 1280 primary MIMVS patients. Grossi and colleagues show
that the only significant risk factor for neurologic event was the use of retrograde
perfusion in high-risk patients with aortic disease.
The purpose of this randomized blinded study is to prospectively evaluate major and minor
neurologic events in patients undergoing right thoracotomy mitral valve surgery with
retrograde perfusion and endoaortic balloon clamp (Endoreturn) or transthoracic clamp. Major
neurologic events will be evaluate through standard neurologic evaluation; minor neurologic
events will be evaluate through magnetic resonance assessment.
MR evaluation will be performed by blinded radiologists. MR will be performed with a 3T
system (Philips INGENIA 3T). The protocol includes conventional sequences for the
morphological and quantitative assessment (3D-FLAIR, 3D-T1-TSE, DWI, T2-FFE) and non
conventional sequences for the white matter microstructural evaluation (Diffusion Tensor
Imaging - DTI with fractional anisotropy and mean diffusivity). No contrast enhanced will be
used.
Patients who have no contraindications will undergo cerebral MR before surgery as baseline
assessment. Then, they will be randomized in one of the 2 groups.
If no contraindications arise in the postoperative period (eg definitive pacemaker
implantation), patients will undergo cerebral MR before the discharge, to highlight the
presence of new ischemic lesions, even clinically silent.
After 6 months, patients who developed new ischemic lesions revealed by the post-operative
cerebral MR will repeat a new MR to assess evolution of cerebral damage Neurologic
assessment will be performed by blinded specialists of the Neurology Department.
Type of the study:
Single center randomized blinded study that will be performed at the University of Turin,
Città della Salute e della Scienza Hospital and will include:
Cardiac Surgery department. Neuroradiology department.
Aims of the study:
To determine the incidence of new lesions on pre-discharge MR in patients undergoing right
mini-thoracotomy mitral valve surgery according to different aortic clamping techniques.
To assess the correlation between clinical neurological peri-procedural events (TIA,
Stroke), and the occurrence of new lesions on pre-discharge MR.
To assess the evolution of new cerebral ischemic lesions between pre-discharge MR and
follow-up MR (more than 6 months later).
To the investigators knowledge this is the first randomized blinded study that will compare
two right mini-thoracotomy techniques for mitral valve surgery on a selected population
(without risk factors for neurological events) with MR.
The result of this study will be able to allow surgeons to choose the best and less
dangerous method in case of mini-invasive operations. This could rapresent a fundamental
step in confirming the efficacy and safety of mini-invasive approaches for mitral valve
surgery and resulting, in addition, in the reduction of the costs of these procedures.
;
Allocation: Randomized, Endpoint Classification: Safety/Efficacy Study, Intervention Model: Parallel Assignment, Masking: Single Blind (Caregiver), Primary Purpose: Treatment
Status | Clinical Trial | Phase | |
---|---|---|---|
Recruiting |
NCT03962023 -
Prognostic Impact of Imaging Parameters in Patients With Primary Mitral Insufficiency by Prolapse (COHORTE-IM)
|
||
Withdrawn |
NCT02624960 -
Safety and Performance of the AccuCinch® System
|
N/A | |
Terminated |
NCT02428010 -
Twelve Transcatheter Mitral Valve Replacement (TMVR) Pilot Study
|
N/A | |
Active, not recruiting |
NCT01533883 -
Cardioband Adjustable Annuloplasty System for Minimally Invasive Mitral Valve Repair
|
N/A | |
Unknown status |
NCT01201070 -
Study of Administration Of Antithrombin in Patients With Low Plasmatic Levels of Antithrombin After Cardiac Surgery
|
Phase 4 | |
Terminated |
NCT00700947 -
Using Beta Blockers to Treat Mitral Regurgitation
|
Phase 1 | |
Completed |
NCT04351984 -
Transcatheter Mitral Valvuloplasty Pilot Study
|
||
Completed |
NCT04231331 -
Ertugliflozin for Functional Mitral Regurgitation
|
Phase 3 | |
Completed |
NCT05742789 -
Effect of Anesthetics on Troponin I and ะก-reactive Protein
|
Phase 1 | |
Recruiting |
NCT02803957 -
Randomized Trial of the Neochord DS1000 System Versus Open Surgical Repair
|
N/A | |
Recruiting |
NCT04153292 -
The ENCIRCLE Trial
|
N/A | |
Completed |
NCT02607527 -
Annular Reshaping of the Mitral Valve for Patients With Mitral Regurgitation Using the Millipede IRIS System
|
N/A | |
Active, not recruiting |
NCT03066050 -
Long Term Follow Up for CTSN Mitral Valve Repair Studies
|
||
Active, not recruiting |
NCT04443218 -
Edwards PASCAL Transcatheter Valve Repair System Registry
|
||
Enrolling by invitation |
NCT04067635 -
Primary Mitral Regurgitation Repair
|
||
Completed |
NCT01966146 -
Examination of Valve Insufficiency Before and After MitraClip or TAVI Procedure by 3D Echocardiography Compared to MRI
|
N/A | |
Recruiting |
NCT01368575 -
Surgical Treatment of Ischemic Mitral Regurgitation
|
Phase 4 | |
Completed |
NCT00001314 -
Investigation of Heart Function in Patients With Heart Valve Defects
|
N/A | |
Terminated |
NCT03285724 -
Safety and Performance Study of the Harpoon Mitral Valve Repair System
|
N/A | |
Withdrawn |
NCT04709042 -
Acquisition of Objective Data During Transapical Neochordae Implantation
|
N/A |